Global  Kaposi Sarcoma Market CAGR of 2.25%  by 2016-2024<span class="rating-result after_title mr-filter rating-result-4062">			<span class="no-rating-results-text">No ratings yet.</span>		</span>
Global  Kaposi Sarcoma Market CAGR of 2.25%  by 2016-2024

Global Kaposi Sarcoma Market
Market Overview
Kaposi sarcoma KS is a cancer that develops from the cells that line lymph or blood vessels, abnormal cells of KS form purple, red, or brown blotches or tumors on the skin called as lesions. Types of Kaposi Sarcoma are:
• Epidemic AIDS-related Kaposi sarcoma
• Classic Mediterranean Kaposi sarcoma
• Endemic African Kaposi sarcoma
• Iatrogenic transplant-related Kaposi sarcoma
• Kaposi sarcoma in HIV negative men who have sex with men
Buy now and get a Beneficial 30% off on this report @
Epidemic or AIDS-related KS is the most common type, develops in people who are infected with HIV, the virus that causes AIDS. In US, treatment of HIV infection with highly active antiretroviral therapy HAART has upshot the cases of epidemic KS and still some patients develop symptoms of KS in the initial months of HAART treatment.
In US, with the AIDS epidemic, the rate of KS increased more than 20 times — peaking at about 47 cases per million people per year in the early 1990s. Early in the AIDS epidemic, patients infected with HIV in the US were estimated to have a 50% probability of having KS. Transplant patients are another slot that gets KS, about 1 in 200 transplant patients in the United States gets KS.
“Imiquimod” Aldara is a topical drug that attunes the immune system and can be applied to the skin to treat certain kinds of warts and helping shrink KS skin lesions, as well. Similarly, Maraviroc Selzentry is also an antiretroviral drug currently being studied for its effect on Kaposi Sarcoma.
Get a Free Sample Copy of this Report @
Market Segmentation:
• By Diagnosis
o Biopsy
o Imaging
o X-ray
o Computed tomography CT or CAT scan
o Endoscopy
o Bronchoscopy
• By Treatment
o Antiretroviral Therapy HAART
o Chemotherapy
o Immunotherapy
• By End User
o Hospital
o Diagnostic centers
o Clinics
• By Geography
o North America US, Canada {Market Share % , Market Size USD Billion , Diagnosis Number }
o Europe UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe {Market Share % , Market Size USD Billion , Diagnosis Number }
o Middle East and Africa GCC Countries, North Africa, South Africa and Rest of Middle East & Africa {Market Share % , Market Size USD Billion , Diagnosis Number }
o Latin America Brazil, Mexico and Rest of Latin America {Market Share % , Market Size USD Billion , Diagnosis Number }
o Asia Pacific China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific {Market Share % , Market Size USD Billion , Diagnosis Number }
o Rest of the World {Market Share % , Market Size USD Billion , Diagnosis Number }
Growth Drivers and Challenges
Looming patent expiries of several blockbuster drugs, high rate of diagnosis of the condition, the easy availability of drugs, with the AIDS being epidemic, significant growth in the organ transplant procedures and introduction of innovative and generic drug as well as therapies are bolstering underlying demand for Kaposi Sarcoma market.
High cost across developing and less developed economies, shortage in supply of drugs due to wide demand-supply gap and less awareness among people limiting Kaposi sarcoma market growth prospects.
To Browse category Reports @
Market Size and Forecast 2016-2024
Kaposi sarcoma market is making strides. According to Goldstein Research, global Kaposi sarcoma market has increased at a CAGR of 2.25% over the forecast period that will exhibit valuation of USD 0.15 billion by 2024 rising from USD 0.11 billion in 2016.
Based on treatments, antiretroviral therapy dominated the global Kaposi sarcoma market owing to the high incidence rate of AIDS-related Kaposi sarcoma and tends to grow at an encouraging pace in the forecast period as well. Biopsy is the first step to diagnose the Kaposi sarcoma while CT scan is usually done to determine if the cancer has spread to the lymph nodes, liver and lungs.
From region wise standpoint, North America is the leading contributor of revenue to the global Kaposi sarcoma market owing to high rate of diagnosis of the condition and the easy availability of drugs. Middle East and Africa region is the promising market of Kaposi sarcoma attributable to increased prevalence of AIDS induced Kaposi sarcoma in Eastern Africa.
Key Market Players:
• Quest Diagnostics
o Synopsis
o Business Strategy
o Product Portfolio
o SWOT Analysis
• Johnson & Johnson
• Merck & Co. Inc.
• Bristol Myers Squibb
• Hoffman-La Roche Inc.
• Pfizer Inc.
• GlaxoSmithKline plc
• Eli Lilly and Co
• Navidea Biopharmaceuticals, Inc.
• MBio Diagnostics
• Cleveland Clinic
• Massachusetts General Hospital
• Mayo Foundation for Medical Education and Research MFMER
• The Johns Hopkins Hospital
• UCLA Health
• Royal Adelaide Hospital
• Cancer Institute Nsw
• Vancouver Coastal Health
Scope Background
Market Synopsis
Market Segmentation
Global Kaposi Sarcoma Market is segmented as follows:
• By diagnosis Market Size, Demand Analysis and Growth Analysis
• By treatment Market Size, Demand Analysis and Growth Analysis
• By end-user Market Size, Demand Analysis and Growth Analysis
Global Kaposi Sarcoma market report covered insights of below mentioned regions:
• North America U.S., Canada {Market Size, Growth Analysis and Opportunity Analysis}
• Latin America Argentina, Mexico, Brazil and Rest of Latin America {Market Size, Growth Analysis and Opportunity Analysis}
• Europe Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe {Market Size, Growth Analysis and Opportunity Analysis}
• Asia-Pacific China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific {Market Size, Growth Analysis and Opportunity Analysis}
• Middle East and North Africa MENA {Market Size, Growth Analysis and Opportunity Analysis}
• Rest of World {Market Size, Growth Analysis and Opportunity Analysis}
Market Dynamics: Growth Drivers, Restraints and Opportunities
• Risk Factors
• Regional Variations
• Current Trends and Developments
To Browse Similar Reports @
About Us:Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe.  We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.
We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.
Contact US:- 
Name: Jennifer Daniel 
US : +1-716-2260907
UK : +447441952057
Organization: Planet Market Reports




Please rate this

Leave a Reply

Close Menu